4.6 Article

Cytokine IL-10, activators of PI3-kinase, agonists of α-2 adrenoreceptor and antioxidants prevent ischemia-induced cell death in rat hippocampal cultures

期刊

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
卷 615, 期 -, 页码 35-43

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2017.01.001

关键词

Ischemia; OGD; Interleukin-10; PI3-Kinase; Alpha-2 adrenoreceptor; Antioxidant enzyme; Neuroprotective agents; Hippocampal cell culture; Global [Ca2+](i) increase; Fura-2; Ca2+ imaging; Cell survival

资金

  1. Ministry of Education and Science of Russian Federation [14.616.21.0039]
  2. Russian Foundation for Basic Research [16-34-00159]
  3. Russian Federation [SP-1057.2015.4, MK 117.2017.4]

向作者/读者索取更多资源

In the present work we compared the protective effect of anti-inflammatory cytokine IL-10 with the action of a PI3-kinase selective activator 740 Y-P, selective agonists of alpha-2 adrenoreceptor, guanfacine and UK-14,304, and compounds having antioxidant effect: recombinant human peroxiredoxin 6 and B27, in hippocampal cell culture during OGD (ischemia-like conditions). It has been shown that the response of cells to OGD in the control includes two phases. The first phase was accompanied by an increase in the frequency of spontaneous synchronous Ca2+-oscillations (SSCO) in neurons and Ca2+-pulse in astrocytes. Spontaneous Ca2+ events in astrocytes during ischemia in control experiments disappeared. The second phase started after a few minutes of OGD and looked like a sharp/avalanche, global synchronic (within 20 s) increase in [Ca2+](i) in many cells. Within 1 h after OGD, a mass death of cells, primarily astrocytes, was observed. To study the protective action of the compounds, cells were incubated in the presence of the neuroprotective agents for 10-40 min or 24 h before ischemia. All the neuroprotective agents delayed a global [Ca2+](i) increase during OGD or completely inhibited this process and increased cell survival. (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据